The article listed above was initially published with incorrect copyright information.Upon publication of this Correction, the copyright of this article changed to BThe Author(s)^.Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Childbirth consists of a three-stage period beginning with uterine, contractions, and ending in the expulsion of the placenta. The aim of this study was the effect of intramuscular hyoscine and hyoscine-promethazine on the duration of labor in nulliparous pregnant women. This study was a triple-blind clinical trial on 213 nulliparous pregnant women who had referred to Amiralmomenin hospital in Zanjan, Iran. Selection of samples was random and done with using 3, 6(1:1:1) of blocking ratio. This study had three groups. The first group received 20 mg hyoscine (group A), the second group 3 cc sterile water (group B), and the third group 20 mg hyoscine and 25 mg promethazine (group C). Data collection tools included a demographic questionnaire, checklist of data, and partograph chart. The mean of the first stage of labor in hyoscine group was 88.95 ± 51.07 min, hyoscine-promethazine 100.05 ± 65.88 min, and control group 170.37 ± 106.87 min. There was significant correlation between A and C and B and C groups (P < 0.001). The mean of the second stage in group A was 46.37 ± 44.60, group B 32.25 ± 17.74, and control group 55.05 ± 44.44 min and a significant relationship was between B and C groups (P = 0.03). The results showed that hyoscine and hyoscine-promethazine can be used to reduce the duration of labor.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.